| HAJEK, Roman, Tomas JELINEK, Vladimir MAISNAR, Luděk POUR, Ivan SPICKA, Jiri MINARIK, Evzen GREGORA, Petr KESSLER, Michal SYKORA, Hana FRANKOVA, Dagmar ADAMOVA, Marek WROBEL, Peter MIKULA, Jiří JARKOVSKÝ, Xenia GATOPOULOU, Sarka VESELA, Joris DIELS, Herve BESSON, Lucie BROŽOVÁ and Tetsuro ITO. Comparative Effectiveness of Daratumumab Monotherapy Versus a Real-World Historical Control from the Czech Republic in Heavily Pretreated and Highly Refractory Multiple Myeloma Patients. In 58th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH). 2016. ISSN 0006-4971. Available from: https://dx.doi.org/10.1182/blood.V128.22.3332.3332. |
Other formats:
BibTeX
LaTeX
RIS
@proceedings{1669586,
author = {Hajek, Roman and Jelinek, Tomas and Maisnar, Vladimir and Pour, Luděk and Spicka, Ivan and Minarik, Jiri and Gregora, Evzen and Kessler, Petr and Sykora, Michal and Frankova, Hana and Adamova, Dagmar and Wrobel, Marek and Mikula, Peter and Jarkovský, Jiří and Gatopoulou, Xenia and Vesela, Sarka and Diels, Joris and Besson, Herve and Brožová, Lucie and Ito, Tetsuro},
booktitle = {58th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)},
doi = {http://dx.doi.org/10.1182/blood.V128.22.3332.3332},
language = {eng},
title = {Comparative Effectiveness of Daratumumab Monotherapy Versus a Real-World Historical Control from the Czech Republic in Heavily Pretreated and Highly Refractory Multiple Myeloma Patients},
url = {https://doi.org/10.1182/blood.V128.22.3332.3332},
year = {2016}
}
TY - CONF
ID - 1669586
AU - Hajek, Roman - Jelinek, Tomas - Maisnar, Vladimir - Pour, Luděk - Spicka, Ivan - Minarik, Jiri - Gregora, Evzen - Kessler, Petr - Sykora, Michal - Frankova, Hana - Adamova, Dagmar - Wrobel, Marek - Mikula, Peter - Jarkovský, Jiří - Gatopoulou, Xenia - Vesela, Sarka - Diels, Joris - Besson, Herve - Brožová, Lucie - Ito, Tetsuro
PY - 2016
TI - Comparative Effectiveness of Daratumumab Monotherapy Versus a Real-World Historical Control from the Czech Republic in Heavily Pretreated and Highly Refractory Multiple Myeloma Patients
UR - https://doi.org/10.1182/blood.V128.22.3332.3332
ER -
HAJEK, Roman, Tomas JELINEK, Vladimir MAISNAR, Luděk POUR, Ivan SPICKA, Jiri MINARIK, Evzen GREGORA, Petr KESSLER, Michal SYKORA, Hana FRANKOVA, Dagmar ADAMOVA, Marek WROBEL, Peter MIKULA, Jiří JARKOVSKÝ, Xenia GATOPOULOU, Sarka VESELA, Joris DIELS, Herve BESSON, Lucie BROŽOVÁ and Tetsuro ITO. Comparative Effectiveness of Daratumumab Monotherapy Versus a Real-World Historical Control from the Czech Republic in Heavily Pretreated and Highly Refractory Multiple Myeloma Patients. In \textit{58th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)}. 2016. ISSN~0006-4971. Available from: https://dx.doi.org/10.1182/blood.V128.22.3332.3332.
|
